Related Experiment Video
Updated: Sep 14, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
"The validation of a multidimensional tool to test knowledge, barriers, and the challenges in screening for
Monisha Mary P1, Ankeeta Menona Jacob1, Avinash Shetty2
1Department of Community Medicine, KS Hegde Medical Academy, Nithyanandanagar Post, Deralakatte, Mangalore, 575018, India.
Background:
The National Coordination Committee (NCC) for the National Tuberculosis Elimination Programme (NTEP) has mandated bi-directional screening for Tuberculosis(TB) and Diabetes Mellitus(DM). The study aims to validate a multidimensional tool to assess the correct knowledge of TB and the barriers and facilitators to TB screening in DM patients.
Aim/Objectives:
To develop and validate a tool for assessing knowledge, barriers, and challenges in TB screening among DM patients by figuring out the Content Validity Ratios and Indices.
Methods And Materials:
A multidimensional scale using deductive methods was designed. Between January 2023 and March 2023, ten subject matter experts were contacted in person or by email to validate the tool. Item Impact Score (IIS, Face Validity), Lawshe's Content Validity Ratio (CVR), and Scale Content Validity Indices (CVI) for relevance were computed. For the final tool, only the items with Item Impact Scores of ≥1.5, CVRs of ≥0.62, and CVIs of ≥0.62 (p-value <0.05) were taken into consideration.
Results:
The Item Impact Score (Face Validity) of all the items accepted as knowledge, barriers, and challenges for TB among DM patients was ≥1.5. Content Validity Ratios (CVR) for the usefulness of all items related to knowledge, barriers, and challenges for TB was ≥0.62. The Scale Content Validity Indices (for relevance), i.e., S-CVI (Average) and S-CVI (Proportional relevance), were ≥0.62 and all the items were accepted.
Conclusions:
The score for Item Impact (IIS), Ratios for Content Validity (CVR), and Indices measuring the content validity of a scale (CVI) in all domains of the final tool were accepted, which contained 38 items.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Diabetes: Symptoms, Diagnosis, and Complications

